# Top 50 Health Care VC (Venture Capital) Funds in Finland in May 2026 ## Butterfly Ventures - Type: VC Fund - Location: Oulu, Oulu, Finland - Relevant deals: 18 - Stages: Seed, Pre-Seed - Focus: Health Care, Software, Information Technology Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm. ## Lifeline Ventures - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 17 - Stages: Seed, Series A - Focus: Software, Health Care, E-Commerce Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland. ## Finnvera Venture Capital - Type: VC Fund - Location: Kuopio, Eastern Finland, Finland - Relevant deals: 15 - Stages: Seed, Series A - Focus: Software, Health Care, Information Technology Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees. ## Tesi - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 15 - Stages: Series A, Series B - Focus: Software, Manufacturing, Health Care Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570 ## Icebreaker.vc - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 11 - Stages: Pre-Seed, Seed, Series A - Focus: Software, Information Technology, Artificial Intelligence Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms. ## Innovestor - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 10 - Stages: Seed, Series A - Focus: Software, Health Care, Manufacturing Welcome to Innovestor! We are a Finnish investment company focusing on venture capital, corporate venturing services, and real estate. ## Voima Ventures - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 10 - Stages: Seed, Pre-Seed - Focus: Biotechnology, Health Care, Software Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors. ## Business Finland - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 9 - Stages: Seed, Grant - Focus: Software, Information Technology, SaaS Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding. ## Inventure - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 7 - Stages: Seed, Series A - Focus: Software, Information Technology, Health Care Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more. ## Reaktor Ventures - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 6 - Stages: Seed, Pre-Seed, Series A - Focus: Software, Internet, Health Care Reaktor Ventures has moved to the next phase by focusing its efforts to actively supporting current portfolio companies. This means that the fund has ended its investment period and is not investing into new companies. Between 2013 and 2018 we have invested into 42 different companies and one early stage fund. We will naturally keep makingfollow-up investments to current portfolio companies. ## Visionplus - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 5 - Stages: Seed, Series A - Focus: Software, Information Technology, Internet WE HELP YOU TO GROW FASTER! ## Nidoco - Type: VC Fund - Location: Stockholm, Stockholms Lan, Sweden - Relevant deals: 4 - Stages: Seed, Series B - Focus: Health Care, Software, Artificial Intelligence Nidoco AB is a Swedish investment company whose strategy is to create long-term value through active ownership of public and private companies. ## VTT Ventures - Type: VC Fund - Location: Espoo, Southern Finland, Finland - Relevant deals: 4 - Stages: Seed, Series A - Focus: Manufacturing, Biotechnology, 3D Technology VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures? ## Oy Hammaren & Co Ab - Type: VC Fund - Location: Finland, Minnesota, United States - Relevant deals: 4 - Stages: Angel, Series A - Focus: Health Care, Wellness, GreenTech Oy Hammaren & Co Ab provides financial services and insurance activities. ## Springvest - Type: VC Fund - Relevant deals: 4 - Stages: Series A - Focus: Biotechnology, Health Care, Energy ## M Ventures - Type: VC Fund - Location: Amsterdam, Noord-Holland, The Netherlands - Relevant deals: 3 - Stages: Series A, Series B, Seed - Focus: Biotechnology, Health Care, Therapeutics Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base. ## First Fellow Partners - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 3 - Stages: Seed, Series A - Focus: Software, SaaS, Enterprise Software A private investment firm run by Risto Siilasmaa and Kim Groop. Grounded in a deeply held set of values around entrepreneurship, trust, integrity and helping solve the world’s problems. We partner with strong and ambitious technology entrepreneurs driven by a mission to fix or build something important in the world. ## Cor Group - Type: VC Fund - Location: Oulu, Oulu, Finland - Relevant deals: 3 - Stages: Seed, Pre-Seed, Series A - Focus: Health Care, Medical, Biotechnology Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services. ## Sitra - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 3 - Stages: Series A, Series C - Focus: Health Care, Biotechnology, Therapeutics Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology. ## Capricorn Partners - Type: VC Fund - Location: Leuven, Vlaams-Brabant, Belgium - Relevant deals: 2 - Stages: Series B, Series A - Focus: Biotechnology, Health Care, Software Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds ## Karolinska - Type: VC Fund - Location: Solna, Stockholms Lan, Sweden - Relevant deals: 2 - Stages: Seed, Series A - Focus: Biotechnology, Health Care, Pharmaceutical Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects. ## Gorilla Capital - Type: VC Fund - Relevant deals: 2 - Stages: Pre-Seed, Seed, Series A - Focus: Software, Information Technology, SaaS Gorilla Capital is a Finnish venture capital fund investing in early stage companies that apply technology to solve real business problems of today. ## Conor Venture Partners - Type: VC Fund - Location: Espoo, Southern Finland, Finland - Relevant deals: 2 - Stages: Series A, Series B, Seed - Focus: Software, Analytics, Semiconductor Conor Venture Partners is a new breed technology venture capital fund and management company. Conor invests in early-stage companies originating from Nordic and Baltic countries. Investment areas include information and communications technology, embedded software, semiconductor technology, electronics, new materials and optics. ## HealthCap - Type: VC Fund - Location: Stockholm, Stockholms Lan, Sweden - Relevant deals: 2 - Stages: Series B, Series A - Focus: Biotechnology, Health Care, Medical HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society. ## Athensmed - Type: VC Fund - Relevant deals: 2 - Stages: Seed, Series A - Focus: Health Care, Medical, mHealth Athensmed Oy ## Metsola Ventures - Type: VC Fund - Location: Espoo, Southern Finland, Finland - Relevant deals: 2 - Stages: Series A - Focus: Medical, mHealth, Health Care Metsola Ventures ## Superhero Capital - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series A - Focus: Software, Information Technology, Internet Early-stage VC searching for the next Superheroes. ## Novartis Venture Fund - Type: VC Fund - Location: Basel, Basel-Stadt, Switzerland - Relevant deals: 2 - Stages: Series B, Series A, Series C - Focus: Biotechnology, Health Care, Therapeutics Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capitalefficiency in the program.We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. SectorsNew therapeutics & platformsMedical devices/implantsDiagnostics/biomarkersDrug delivery/biopolymersGeographyUSA/CanadaEuropeSwitzerlandAsia/Pacific ## European Investment Bank - Type: VC Fund - Location: Luxembourg, Luxembourg, Luxembourg - Relevant deals: 2 - Stages: Debt Financing, Post-IPO Debt - Focus: Biotechnology, Health Care, Software European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg. ## Pontos Group - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 2 - Focus: Genetics, Hospital, Automotive Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal. ## Novo Holdings - Type: VC Fund - Location: Hellerup, Hovedstaden, Denmark - Relevant deals: 2 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Novo Holdings is a world-leading life science investor with a focus on creating long-term value. ## EQT life science - Type: VC Fund - Location: Amsterdam, Noord-Holland, The Netherlands - Relevant deals: 2 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Therapeutics EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders. ## Nina Capital - Type: VC Fund - Location: Barcelona, Catalonia, Spain - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series A - Focus: Health Care, Artificial Intelligence, Medical We deploy early stage capital to fuel the growth of need-driven health technology companies. ## Broadview Ventures - Type: VC Fund - Location: Boston, Massachusetts, United States - Relevant deals: 2 - Stages: Series A, Seed, Debt Financing - Focus: Health Care, Biotechnology, Medical Device Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science. ## Maki.vc - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 2 - Stages: Seed, Series A - Focus: Software, SaaS, E-Commerce Maki.vc is an early-stage venture capital firm partnering with deep tech & brand-driven startups obsessed with challenging category norms. ## Sofinnova Partners - Type: VC Fund - Location: Paris, Ile-de-France, France - Relevant deals: 2 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. ## Vesalius Biocapital Partners - Type: VC Fund - Location: Strassen, Luxembourg, Luxembourg - Relevant deals: 2 - Stages: Series B, Series A, Series C - Focus: Biotechnology, Health Care, Medical Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data. ## Cascara Ventures - Type: VC Fund - Location: Brussels, Brussels Hoofdstedelijk Gewest, Belgium - Relevant deals: 1 - Stages: Series A, Seed, Series B - Focus: Medical, Health Care, Biotechnology 96 Normal 0 false false false EN-GB X-NONE X-NONE ## Zhejiang Huahai Pharmaceutical - Type: VC Fund - Location: Linhai, Zhejiang, China - Relevant deals: 1 - Stages: Series A - Focus: Biotechnology, Medical Device, Pharmaceutical Zhejiang Huahai Pharmaceutical Co. Ltd. is a Phermaceutical Company. ## Takoa Invest - Type: VC Fund - Relevant deals: 1 - Stages: Seed, Series B, Series C - Focus: Biotechnology, Mobile, Retail Takoa Invest is a Finnish family-owned investment company that owns and develops companies and properties with growth potential in Finland and abroad. Takoa Invest is a Finnish family-owned investment company. It owns and develops companies and properties with growth potential in Finland and abroad. ## Inveni Capital - Type: VC Fund - Location: Helsinki, Southern Finland, Finland - Relevant deals: 1 - Focus: Medical, Health Care, Biotechnology Inveni Capital is a venture capital management company focused on investments in early to growth stage life sciences companies. ## High-Tech Grunderfonds - Type: VC Fund - Location: Bonn, Nordrhein-Westfalen, Germany - Relevant deals: 1 - Stages: Seed, Series A - Focus: Software, Information Technology, Biotechnology High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG. ## Bold Capital Partners - Type: VC Fund - Location: Santa Monica, California, United States - Relevant deals: 1 - Stages: Series A, Seed, Series B - Focus: Health Care, Software, Biotechnology A collection of entrepreneurs, engineers, physicists, doctors, surfers, and musicians who are committed to helping entrepreneurs achieve their dreams of changing the world. ## IPF Partners - Type: VC Fund - Location: Luxembourg, Luxembourg, Luxembourg - Relevant deals: 1 - Stages: Series B, Series C - Focus: Health Care, Medical, Hospital IPF Partners is a alternative financing provider focused on the European healthcare sector. IPF invests directly in emerging, commercial-stage European pharma/biotech, medtech and diagnostics companies. ## Spintop Ventures - Type: VC Fund - Location: Stockholm, Stockholms Lan, Sweden - Relevant deals: 1 - Stages: Seed, Series A - Focus: Software, Information Technology, SaaS Founded in 2009, Spintop Ventures is a venture capital firm backed by a network of successful tech entrepreneurs who have invested in Spintop alongside institutional investors, family offices and some of the most experienced private investors in early stage growth companies. ## Emerald Technology Ventures - Type: VC Fund - Location: Zürich, Zurich, Switzerland - Relevant deals: 1 - Stages: Series B, Series A - Focus: Manufacturing, Energy, Software We provide venture capital for companies with cutting-edge technology that solves key issues in the transition to a net zero emissions world. ## Way to Wellville - Type: VC Fund - Location: Astoria, Oregon, United States - Relevant deals: 1 - Stages: Series B, Series A - Focus: Software, Health Care, Medical Wellville is a 10-year national nonprofit project to achieve equitable wellbeing. We support the efforts of The Wellville 5: Five US communities. ## Gerresheimer Glas - Type: VC Fund - Location: Düsseldorf, Nordrhein-Westfalen, Germany - Relevant deals: 1 - Stages: Seed - Focus: Health Care, Medical Device Gerresheimer is a leading global partner to the pharma and healthcare industry. With our specialty glass and plastic products, we contribute to health and well-being. We have worldwide operations and about 10,000 employees manufacture our products in local markets, close to our customers. With our plants in Europe, North America, South America, andAsia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, refillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry. ## Volvo Cars - Type: VC Fund - Location: Göteborg, Vastra Gotaland, Sweden - Relevant deals: 1 The first mass-produced Volvo car rolled off the production line in Gothenburg in 1927. Since then, they have delivered a steady stream of cars equipped with world-leading innovations. Today, they are one of the most well-known and respected car brands in the world with sales in about 100 countries.Volvo Car Group (Volvo Cars) is owned byZhejiang Geely Holding (Geely Holding) of China. Volvo Cars formed part of the Swedish Volvo Group until 1999 when Ford Motor Company bought the company. In 2010, Geely Holding acquired Volvo Cars.They produce premium cars with the following body types: Sedans, Estates/Sportswagons, Cross Country vehicles, SUVs, and Convertibles. Their cars are characterized by intuitive, human-focused, functional Scandinavian design and good craftsmanship.Relative to the strength of the brand, Volvo Cars is a small producer with global sales reaching 421,951 cars in 2012. Their largest markets are the United States, Sweden, China, Germany, and the UK. Their corporate and brand strategy is ”Designed Around You” and puts people at the heart of everything they do.As a responsible company, they want to contribute to a more sustainable society. To ensure that they are in harmony with customers and society, they do their part by spearheading the development of sustainable mobility - from plug-in hybrids and all-electric cars to active cooperation in a partnership project on road trains.They are proud to continuously deliver world-first solutions; innovations that put people first, by saving and simplifying their lives. Volvo Cars was owned by AB Volvo until 1999 when it was acquired by the Ford Motor Company as part of its Premier Automotive Group. Geely Holding Group then acquired Volvo Cars from Ford in 2010. ## Heraeus - Type: VC Fund - Location: Hanau, Hessen, Germany - Relevant deals: 1 - Stages: Seed, Series A - Focus: Biotechnology, Manufacturing, Therapeutics Heraeus, the technology group headquartered in Hanau, Germany, is a leading international family-owned portfolio company. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co